FCA Qui Tams Are Unconstitutional, Eli Lilly Tells Justices

By Mark Payne · March 30, 2026, 6:27 PM EDT

The False Claims Act's whistleblower provisions are unconstitutional, drugmaker Eli Lilly has told the U.S. Supreme Court, asking it to overturn a Seventh Circuit decision upholding a $183 million trial win...

To view the full article, register now.

Documents

Case Information

Case Title

Ronald J. Streck v. Eli Lilly and Company

Case Number

23-2134

Court

Appellate - 7th Circuit

Nature of Suit

3375 False Claims Act

Date Filed

June 07, 2023


Case Title

Ronald J. Streck v. Eli Lilly and Company

Case Number

23-2216

Court

Appellate - 7th Circuit

Nature of Suit

3375 False Claims Act

Date Filed

June 20, 2023


Case Title

Ronald J. Streck v. Eli Lilly and Company

Case Number

23-2958

Court

Appellate - 7th Circuit

Nature of Suit

3375 False Claims Act

Date Filed

October 11, 2023


Case Title

Ronald Streck v. Eli Lilly and Company

Case Number

23-3035

Court

Appellate - 7th Circuit

Nature of Suit

3375 False Claims Act

Date Filed

October 23, 2023


Case Title

Ronald Streck v. Eli Lilly and Company

Case Number

24-1352

Court

Appellate - 7th Circuit

Nature of Suit

3375 False Claims Act

Date Filed

March 07, 2024


Case Title

Ronald Streck v. Eli Lilly and Company

Case Number

24-1884

Court

Appellate - 7th Circuit

Nature of Suit

3375 False Claims Act

Date Filed

May 20, 2024


Case Title

Eli Lilly and Company, Petitioner v. United States, et al., ex. rel., Ronald J. Streck

Case Number

25-1126

Court

Supreme Court

Nature of Suit

3375 False Claims Act

Date Filed

March 27, 2026